K-numberK243290
Device nameBTL-785MJ
ApplicantBTL Industries, Inc.
Product codeNUW
Device classClass II
Decision dateMay 9, 2025
DecisionSubstantially Equivalent
Regulation890.5850
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The BTL-785MJ is an electrostimulation device used to relieve muscle spasm symptoms, treat temporomandibular joint (TMJ) dysfunction and pain, support muscle re-education, increase blood flow, and maintain or increase mandibular range of motion. It consists of a main control unit with a color touchscreen, handpiece, holding arm, connection cables, and single-use applicator pads that deliver electrical stimulation therapy.

Technological characteristics

The BTL-785MJ uses similar electrical stimulation technology with comparable output parameters to the predicate device: preset pulse widths (up to 150 μs and 488 μs), output frequencies (up to 200 Hz and 0.67 Hz), output currents (up to 80 mA), and therapy duration (20–60 minutes). Both devices use rectangular pulse shapes, pad-type single-use applicators with conductive ink and hydrogel, and operate at the same electrical safety class (Class II, BF) with identical voltage ranges (100–120 V AC and 200–240 V AC, 50/60 Hz).

Test standards cited

IEC 60601-1, IEC 60601-1-2, IEC 60601-2-10, IEC 60601-1-6, IEC 62304, ISO 14971, ISO 10993-1, ISO 10993-5, and ISO 10993-10. The device complies with medical electrical equipment safety and biocompatibility standards for nerve and muscle stimulators.

Substantial equivalence argument

The BTL-785MJ shares the same therapeutic principle of action (electrical stimulation), identical indications for use, matching prescription-use classification, and substantially similar electrical and mechanical specifications compared to the predicate device (D function, K203525). Any differences in system weight and dimensions have no significant influence on safety or effectiveness because they relate only to device form factor, not the core stimulation technology or clinical performance.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →